Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01835301|
Recruitment Status : Unknown
Verified August 2014 by Medstar Health Research Institute.
Recruitment status was: Active, not recruiting
First Posted : April 18, 2013
Last Update Posted : August 11, 2014
|Condition or disease|
|In-stent Coronary Artery Restenosis|
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation|
|Study Start Date :||November 2011|
|Estimated Primary Completion Date :||December 2015|
Patients who received a DES stent > 3 years ago.
Patients who received BMS stents > 3 years ago.
- Plaque composition [ Time Frame: During hospital stay, about 2 days. ]This study aims to test the hypothesis that plaque composition differs within the stent between BMS and DES. It is possible that a difference in plaque composition seen within the stent may be contributory to the late thrombotic events seen more frequently with DES.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01835301
|United States, District of Columbia|
|Medstar Washington Hospital Center|
|Washington, District of Columbia, United States, 20010|
|Principal Investigator:||Ron Waksman, MD||Medstar Washington Hospital Center|